World's Best Scientists 2026 revealed!
Michael H. Davidson

Michael H. Davidson

D-Index & Metrics

Medicine

D-Index
129
Citations
62502
World Ranking
2592
National Ranking
1454

Overview

Michael H. Davidson is affiliated with the University of Chicago in the United States. Their primary field of study is Medicine, with a significant focus on Psychiatry and Mental Health, Genetics, Molecular Biology, Pharmacology, and Pulmonary and Respiratory Medicine. The scope of their research spans several topics including schizophrenia research and treatment, genetic associations and epidemiology, health systems and economic evaluations, genomic variations and chromosomal abnormalities, genomics and rare diseases, treatment of major depression, and pharmacological receptor mechanisms and effects.

Davidson's recent papers include the following:

  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia, 2022, published in Nature
  • IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial, 2021, The Lancet
  • Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia, 2022, JAMA Psychiatry
  • Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, 2020, Journal of the American Society of Nephrology
  • Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations, 2023, Nature Genetics

Frequent coauthors in Davidson's research include:

  • Mark Weiser
  • Tim B. Bigdeli
  • Stanley V. Catts
  • Kenneth L. Davis
  • R. Luthringer

The venues where Davidson has frequently published include:

  • Lung Cancer
  • Schizophrenia Bulletin
  • UNC Libraries
  • American Journal of Psychiatry
  • Schizophrenia Bulletin Open

Additionally, Davidson has contributions in book publications with two books titled Distressing Language published by New York University Press eBooks in 2022.

Best Publications

  • Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)

    Stephen Hulley;Curt Furberg;Elizabeth Barrett-Connor;Jane Cauley

  • Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* trial)

    Peter H Jones;Michael H Davidson;Evan A Stein;Harold E Bays

  • Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation

    John D. Brunzell;Michael Davidson;Curt D. Furberg;Ronald B. Goldberg

  • Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

    John D. Brunzell;Michael Davidson;Curt D. Furberg;Ronald B. Goldberg

  • Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial

    Michael H. Davidson;Jonathan Hauptman;Mario DiGirolamo;John P. Foreyt

  • AACE comprehensive diabetes management algorithm 2013.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

    Paul S. Jellinger;Yehuda Handelsman;Paul D. Rosenblit;Zachary T. Bloomgarden

  • Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.

    William S. Harris;Michael Miller;Ann P. Tighe;Michael H. Davidson

  • Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

    Christopher P. Cannon;Sukrut Shah;Hayes M. Dansky;Michael Davidson

  • Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.

    Michael H Davidson;Thomas McGarry;Robert Bettis;Lorenzo Melani

  • Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor

    James W. Nawrocki;Stuart R. Weiss;Michael H. Davidson;Dennis L. Sprecher

  • Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction

    Marcelo F. Di Carli;Michael Davidson;Roderick Little;Sandeep Khanna

  • Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

    Stephen J. Nicholls;A. Michael Lincoff;Michelle Garcia;Dianna Bash

  • Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

    Michael H Davidson;Evan A Stein;Harold E Bays;Kevin C Maki

  • Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

    James M. McKenney;Michael H. Davidson;Terry A. Jacobson;John R. Guyton

  • Risk for Myopathy With Statin Therapy in High-Risk Patients

    Christie M. Ballantyne;Alberto Corsini;Michael H. Davidson;Hallvard Holdaas

  • Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

    Rebecca G. Bakker-Arkema;Michael H. Davidson;Robert J. Goldstein;Jean Davignon

  • Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    Maciej Banach;Manfredi Rizzo;Peter P Toth;Michel Farnier

  • Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids

    Michael H. Davidson

  • Effect of Pioglitazone Compared With Glimepiride on Carotid Intima-Media Thickness in Type 2 Diabetes

    Theodore Mazzone;Peter M. Meyer;Steven B. Feinstein;Michael H. Davidson

Frequent Co-Authors

Mark Weiser
Mark Weiser Sheba Medical Center
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Kenneth L. Davis
Kenneth L. Davis Icahn School of Medicine at Mount Sinai
Abraham Reichenberg
Abraham Reichenberg Icahn School of Medicine at Mount Sinai
Harold E. Bays
Harold E. Bays Louisville Metabolic and Atherosclerosis Research Center
Evan A. Stein
Evan A. Stein Medpace (United States)
Philip D. Harvey
Philip D. Harvey University of Miami
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Vahram Haroutunian
Vahram Haroutunian Icahn School of Medicine at Mount Sinai
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative medical careers or expanding their qualifications, many flexible online pathways are available beyond traditional medical school. Healthcare administration is a popular route, especially with top online mha programs that are cahme accredited. These programs equip graduates for leadership roles in hospitals, clinics, and healthcare organizations without requiring years of clinical experience.

Registered nurses can also boost their credentials through rn to bsn programs. Such programs, especially those requiring no clinicals, are streamlined for working professionals eager to advance their nursing careers.

For nurses seeking the highest level of clinical practice, the shortest online dnp program options provide accelerated learning while maintaining high standards. Additionally, choosing a dnp program without clinical hours can be an appealing solution for those who wish to focus on leadership, education, or research in nursing.

These flexible online degrees open diverse career pathways in healthcare, catering to those balancing education with busy work and personal commitments.

Best Scientists Citing Michael H. Davidson

Trending Scientists

Recently Published Articles